HDAC inhibition enhances T-cell mediated anti-tumor immune responses by increasing the presence of tumor-infiltrating CD8+ T cells and molecules involved in antigen processing and presentation, while also blocking Treg and myeloid-derived suppressor cells (MDSCs) infiltration55. Here, HDAC9 is linked to neoplasm.